Chairperson(s) : TBD (Affiliation, Country)
Panel(s) : Ji-Yong Jang (National Health Insurance Service Ilsan Hospital, Republic of Korea), Yun Kyung Cho (University of Ulsan, Republic of Korea)
-
Bempedoic acid: LDL-C lowering beyond statins - evidence and clinical role
Che Wan Lim Catholic Kwandong University, Republic of Korea 08:30~08:50 -
Optimizing non-statin therapy: PCSK9 inhibitors and inclisiran
TBD (Name) TBD (Affiliation, Country) 08:50~09:10 -
Emerging Lp(a)-lowering therapies: siRNA, ASO, and beyond
Yu-Chen Wang Asia University, Taiwan 09:10~09:30 - Panel Discussion 09:30~10:00
Chairperson(s) : TBD (Affiliation, Country)
Panel(s) : Sang Yong Kim (Chosun University, Republic of Korea), Ji Woong Yoo (Hallym University, Republic of Korea), Mi-Hyang Jung (The Catholic University of Korea, Republic of Korea)
-
Lipid-lowering therapy in people living with HIV (PLWH)
So Ree Kim Korea University, Republic of Korea 08:30~08:48 -
Lipid-lowering therapy in cancer patients and survivors
Hiroshi Akazawa Kanazawa Medical University, Japan 08:48~09:06 -
Lipid-lowering therapy in patients with CKD
Eun-sil Koh The Catholic University of Korea, Republic of Korea 09:06~09:24 -
Cardiovascular prevention in hemodialysis: is omega-3 back?
Sang Ho Jo Hallym University, Republic of Korea 09:24~09:42 - Panel Discussion 09:42~10:00
Chairperson(s) : TBD (Affiliation, Country)
Panel(s) : Nari Kim (Inje University, Republic of Korea), Jong-Gil Park (Korea Research Institute of Bioscience and Biotechnology, Republic of Korea), Dong Kyu Choi (Kyungpook National University, Republic of Korea)
-
Ion channels in atherosclerosis: from calcium flux to vascular dysfunction
Sung Joon Kim Seoul National University, Republic of Korea 08:30~08:50 -
Energy metabolism and lipid oxidation in cardiometabolic pathophysiology
Jin Han Inje University, Republic of Korea 08:50~09:10 -
Lp(a): from lipoprotein biology to atherosclerotic cardiovascular disease
Jung-Woo Son Yonsei University, Republic of Korea 09:10~09:30 - Panel Discussion 09:30~10:00
Chairperson(s) : Hack-Lyoung Kim (Seoul National University, Republic of Korea)
Panel(s) : Seok Oh (Chonnam National University, Republic of Korea)
-
Sex differences in lipid profiles and residual cardiovascular risk
Soo Jin Kim Kosin University, Republic of Korea 12:45~13:00 -
Early-onset dyslipidemia in young adults: screening strategies and lifetime ASCVD risk assessment
Jaehyun Bae Hallym University, Republic of Korea 13:00~13:15 -
Menopause and cardiometabolic transition: optimizing lipid management in midlife women
In Jeong Cho Ewha Womans University, Republic of Korea 13:15~13:30 - Panel Discussion 13:30~13:45
Chairperson(s) : TBD (Affiliation, Country)
- 2026 KSoLA Award Ceremony for Scientific Excellence 12:45~12:50
- 2026 KSoLA Award Ceremony for Young Investigator 12:50~12:55
-
The quiet signal, no longer - triglyceride at the crossroads of insulin resistance and cardiometabolic risk
Cheol-Young Park Sungkyunkwan University, Republic of Korea 12:55~13:15 - Q&A 13:15~13:20
-
The health information on social media: the reliability and professionals’ rersponsibility
Il Hak Lee Yonsei University, Republic of Korea 13:20~13:40 - Q&A 13:40~13:45
Chairperson(s) : TBD (Affiliation, Country)
Panel(s) : Eunju Park (Kyungnam University, Republic of Korea), Jee Hee Yoo (Chung-Ang University, Republic of Korea)
-
Korean epidemiology and risk modifiers for establishing LDL-C goal strategies
Jong Han Choi Konkuk University, Republic of Korea 13:45~14:03 -
Practical algorithm for intensive lipid lowering therapy in the 2026 Korean guidelines
Jaehoon Chung Gachon University, Republic of Korea 14:03~14:21 -
Nutritional management and lifestyle modification tailored to the Korean dietary pattern
Garam Cho Hannam University, Republic of Korea 14:21~14:39 -
Optimized lipid management for special populations
Byung Sik Kim Hanyang University, Republic of Korea 14:39~14:57 - Panel Discussion 14:57~15:15
Chairperson(s) : TBD (Affiliation, Country)
Panel(s) : Bom Lee (CHA University, Republic of Korea), Hyung Joon Joo (Korea University, Republic of Korea)
-
Evolution of vulnerable plaques: from natural history to preventive intervention
Jin Ho Lee Kyung Hee University, Republic of Korea 13:45~14:03 -
High-risk plaque features on CCTA: identification and clinical implications
Sang Yoon Lee Sungkyunkwan University, Republic of Korea 14:03~14:21 -
Intravascular imaging of vulnerable plaques: insights from IVUS and OCT
TBD (Name) TBD (Affiliation, Country) 14:21~14:39 -
Coronary physiology and plaque vulnerability: integrative relationship and prognostic implications
Seok Hun Yang Seoul National University, Republic of Korea 14:39~14:57 - Panel Discussion 14:57~15:15
Chairperson(s) : TBD (Affiliation, Country)
Panel(s) : Bo Kyung Koo (Seoul National University, Republic of Korea), Kyung-Jin Kim (Ewha Womans University, Republic of Korea), Heesun Lee (Seoul National University, Republic of Korea)
-
Fatty liver and residual cardiovascular risk: epidemiology and clinical implications
Eun Jung Rhee Sungkyunkwan University, Republic of Korea 13:45~14:05 -
From lipotoxicity to atherosclerosis: MASLD/MetALD subtypes and cardiovascular risk
Su Jong Yu Seoul National University, Republic of Korea 14:05~14:25 -
Therapeutic strategies for cardiometabolic risk reduction in MASLD
Toru Miyoshi Okayama University, Japan 14:25~14:45 - Panel Discussion 14:45~15:15
Chairperson(s) : TBD (Affiliation, Country)
Panel(s) : Hyung-Min Kwon (Seoul National University, Republic of Korea), Minjeong Kim (Ewha Womans University, Republic of Korea)
-
PCSK9 inhibition in primary prevention: insights from VESALIUS-CV and clinical implications
Doo Sun Sim Chonnam National University, Republic of Korea 16:10~16:30 -
Low LDL-C and brain safety: risk of hemorrhagic stroke and cognitive dysfunction
Kwang-Yeol Park Chung-Ang University, Republic of Korea 16:30~16:50 -
Early combination therapy in primary prevention
Hoyoun Won Chung-Ang University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : TBD (Affiliation, Country)
Panel(s) : Jang Hoon Lee (Kyungpook National University, Republic of Korea)
-
CETP inhibition revisited: obicetrapib for LDL-C reduction and ASCVD risk management
Mariko Harada-Shiba Osaka Medical and Pharmaceutical University, Japan 16:10~16:30 -
APOC3 inhibition: targeting triglyceride-rich lipoproteins and residual risk
Jin Wi Gachon University, Republic of Korea 16:30~16:50 -
ANGPTL3 inhibition: expanding therapeutic opportunities beyond LDL-C
Hye Moon Chung Kyung Hee University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : TBD (Affiliation, Country)
Panel(s) : Jung Myung Lee (Sahmyook Medical Center, Republic of Korea), Jong Han Choi (Konkuk University, Republic of Korea)
-
Defining residual cardiovascular risk in the post-LDL era: unmet needs and mechanisms
Hyung Joon Joo Korea University, Republic of Korea 16:10~16:30 -
Targeting residual risk: Lp(a), triglyceride-rich lipoproteins, and inflammation
Sung Gyun Ahn Yonsei University, Republic of Korea 16:30~16:50 -
Beyond less is more: navigating residual thrombotic and inflammatory risk in AF and stable CAD
Satoshi Yasuda Tohoku University, Japan 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Min Sun Kim (University of Ulsan, Republic of Korea)
Panel(s) : Song-Yi Kim (Jeju National University, Republic of Korea), Heung Yong Jin (Jeonbuk National University, Republic of Korea)
-
Lipid remodeling of adipose tissue: the hidden link between obesity and atherosclerosis
Yun-Hee Lee Seoul National University, Republic of Korea 16:10~16:30 -
Remnant cholesterol and residual cardiovascular risk in obesity
Young Sang Lyu Chosun University, Republic of Korea 16:30~16:50 -
Dual targeting of lipid and weight: emerging therapies and clinical strategies
Chang Hee Jung University of Ulsan, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
